Why the study?
Does intravenous adrenalin infusion and corticosteroid treatment improve coagulation parameters in patients with von Willebrand's disease?
Does intravenous adrenalin infusion and corticosteroid treatment improve coagulation parameters in patients with von Willebrand's disease?
Corticosteroid treatment may improve factor VIII procoagulant activity in patients with von Willebrand's disease who have relatively high baseline AHF activity, potentially offering a preoperative strategy.
Answers are grounded in this paper and cite their sources.
Corticosteroid effects on FVIII in vWD remain hypothesis-generating; controlled trials needed before any perioperative consideration.
Intravenous adrenalin infusion (5 micrograms/kg, at most 160 micrograms in 10 min) normalized partial thromboplastin time (PTT) and ristocetin induced platelet aggregation (RIPA) in 4 of the 14 patients with von Willebrand's disease (VWD) in a short period of time. Although mean factor VIII (F-VIII) procoagulant activity was almost doubled 5 min following infusion, this was mainly observed in patients with relatively high baseline (> 2%) AHF activity. Mean F-VIII procoagulant activity rose by more than 100% following 10 days of corticosteroid treatment (deltacortil 2 mg/kg/day, at most 60 mg/day). PTT became normal in 6 of the 11 patients, but RIPA normalized only in 2. The improvement of RIPFA did not correspond to bleeding time in every patient. These results may suggest that if the baseline AHF activity is relatively high (greater than or equal to 9.5%), corticosteroid could be tried before schedule surgical intervention in patients with VWD.
No takes yet. Share an insight, caveat, or question.
Özsoylu et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: